Literature DB >> 17596194

Mouse model mimics multiple sclerosis in the clinico-radiological paradox.

Jens Wuerfel1, Eva Tysiak, Timour Prozorovski, Maureen Smyth, Susanne Mueller, Joerg Schnorr, Matthias Taupitz, Frauke Zipp.   

Abstract

The value of experimental autoimmune encephalomyelitis (EAE), an animal model of multiple sclerosis, in deriving novel diagnostic and therapeutic input has been subject to recent debate. This study is the first to report a disseminated distribution of plaques including cranial nerves, prior to or at early stages of disease in murine adoptive transfer EAE, irrespective of the development of clinical symptoms. We induced EAE by adoptive proteolipid protein-specific T-cell transfer in 26 female SJL/J mice, and applied high-field-strength magnetic resonance imaging (MRI) scans longitudinally, assessing blood-brain barrier (BBB) disruption by gadopentate dimeglumine enhancement. We visualized inflammatory nerve injury by gadofluorine M accumulation, and phagocytic cells in inflamed tissue by very small anionic iron oxide particles (VSOP-C184). MRI was correlated with immunohistological sections. In this study, we discovered very early BBB breakdown of white and grey brain matter in 25 mice; one mouse developed exclusively spinal cord inflammation. Widely disseminated contrast-enhancing lesions preceded the onset of disease in 10 animals. Such lesions were present despite the absence of any clinical disease formation in four mice, and coincided with the first detectable symptoms in others. Cranial nerves, predominantly the optic and trigeminal nerves, showed signal intensity changes in nuclei and fascicles of 14 mice. At all sites of MRI lesions we detected cellular infiltrates on corresponding histological sections. The discrepancy between the disease burden visualized by MRI and the extent of disability indeed mimics the human clinico-radiological paradox. MRI should therefore be implemented into evaluational in vivo routines of future therapeutic EAE studies.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17596194     DOI: 10.1111/j.1460-9568.2007.05644.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  27 in total

1.  Enhancing the ability of experimental autoimmune encephalomyelitis to serve as a more rigorous model of multiple sclerosis through refinement of the experimental design.

Authors:  Mitchell R Emerson; Ryan J Gallagher; Janet G Marquis; Steven M LeVine
Journal:  Comp Med       Date:  2009-04       Impact factor: 0.982

2.  Clinical trials in multiple sclerosis: current and future requirements - potential pitfalls.

Authors:  P Rieckmann
Journal:  J Neurol       Date:  2008-12       Impact factor: 4.849

3.  Utilizing different methods for visualizing susceptibility from a single multi-gradient echo dataset.

Authors:  Gopal Varma; Steen Fjord Pedersen; Matthias Taupitz; Rene Michael Botnar; Hannes Dahnke; Stephen Frederick Keevil; Tobias Schaeffter
Journal:  MAGMA       Date:  2009-07-31       Impact factor: 2.310

Review 4.  Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.

Authors:  Thomas Tourdias; Vincent Dousset
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

5.  Natural triterpenes modulate immune-inflammatory markers of experimental autoimmune encephalomyelitis: therapeutic implications for multiple sclerosis.

Authors:  R Martín; M Hernández; C Córdova; M L Nieto
Journal:  Br J Pharmacol       Date:  2012-07       Impact factor: 8.739

6.  Cortical atrophy in experimental autoimmune encephalomyelitis: in vivo imaging.

Authors:  Allan MacKenzie-Graham; Gilda A Rinek; Andrea Avedisian; Stefan M Gold; Andrew J Frew; Cynthia Aguilar; David R Lin; Elizabeth Umeda; Rhonda R Voskuhl; Jeffry R Alger
Journal:  Neuroimage       Date:  2011-12-13       Impact factor: 6.556

7.  Myelin basic protein induces inflammatory mediators from primary human endothelial cells and blood-brain barrier disruption: implications for the pathogenesis of multiple sclerosis.

Authors:  T G D'Aversa; E A Eugenin; L Lopez; J W Berman
Journal:  Neuropathol Appl Neurobiol       Date:  2013-04       Impact factor: 8.090

8.  Beyond blood brain barrier breakdown - in vivo detection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI.

Authors:  Eva Tysiak; Patrick Asbach; Orhan Aktas; Helmar Waiczies; Maureen Smyth; Joerg Schnorr; Matthias Taupitz; Jens Wuerfel
Journal:  J Neuroinflammation       Date:  2009-08-06       Impact factor: 8.322

9.  MR imaging of inflammation during myelin-specific T cell-mediated autoimmune attack in the EAE mouse spinal cord.

Authors:  Kristine M Robinson; Jeffrey M Njus; Daniel A Phillips; Thomas M Proctor; William D Rooney; Richard E Jones
Journal:  Mol Imaging Biol       Date:  2009-12-01       Impact factor: 3.488

Review 10.  New developments in understanding and treating neuroinflammation.

Authors:  C Infante-Duarte; S Waiczies; J Wuerfel; F Zipp
Journal:  J Mol Med (Berl)       Date:  2008-01-15       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.